Why Publish With JNCI Cancer Spectrum?

JNCI Cancer Spectrum is a peer-reviewed open access journal which publishes online. The journal publishes manuscripts describing new findings of particular significance across a full range of clinical and translational cancer research, including prevention, screening, and treatment, as well as clinically relevant epidemiologic, public health, and policy research.

In addition to novel results, the journal also considers studies with meaningful confirmatory or negative findings, and it encourages systematic reviews, meta-analyses, and expert reviews of important topics. The journal also invites scholarly manuscripts discussing emerging hypotheses and research priorities.

Learn more about the benefits of publishing your research with JNCI Cancer Spectrum below:

Quality-first, Impactful Research

• JNCI Cancer Spectrum employs a process of rigorous yet rapid review of submitted manuscripts so that findings of high scientific and medical interest can be published with minimum delay.

• The journal is fully open access, meaning your research is free to read and can be accessed globally. An open access license increases the visibility of your research and creates more opportunities for fellow researchers to read, share, cite, and build upon your findings.

• Globally, research published in JNCI Cancer Spectrum has received noteworthy media attention. In 2023, two articles examining the evolving role of AI in healthcare showcased the appetite for research in this area:

  • Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information

  • Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

• In utero exposure to antiemetic and risk of adult-onset colorectal cancer received the highest Altmetric attention score for research published in JNCI Cancer Spectrum in 2023, with a score of 391.

• Impact: JNCI Cancer Spectrum recently received its inaugural Impact Factor of 3.4 (Clarivate, 2023) and boasts a CiteScore of 7.7 (Scopus, 2023).

• Article-level metrics, including usage, citations, and Altmetric scores are available for all articles published in the journal, allowing you to understand the reach of your research, and the attention it is receiving online.

Extensive Reach for Your Research

• JNCI Cancer Spectrum is home to a global authorship community and welcomes submissions highlighting research with global outcomes.

• As part of our author community, you may benefit from additional exposure on JNCI’s social media channels. @JNCI_Now, the journal’s official X account, boasts a huge following and regular engagement, meaning your work could be amplified to a global audience and gain attention from prominent media outlets.

• JNCI Cancer Spectrum research may also feature in wider thematic online collections from Oxford University Press, such as the Women in Cancer Research Collection, or Health Equity: Social Determinants of Health, directly connecting your work to researchers examining a particular topic. These thematic online collections curate articles from multiple OUP journals on a specific and timely topic, garnering further exposure and attention for these articles.

• JNCI Cancer Spectrum and JNCI: Journal of the National Cancer Institute are committed to supporting and advancing diversity, equity, and inclusion in our editorial practices and published content on cancer research. We welcome and encourage submissions from authors of all backgrounds, will actively recruit reviewers and editorial board members from diverse backgrounds, will continue to foster a bias-free peer review, and will publish papers that use inclusive language.

• The journal is indexed in DOAJ, Web of Science, Scopus, PMC, MEDLINE.

Expert Editorial Board

• JNCI Cancer Spectrum has an expert editorial board, appointed based on their passion for and contribution to the field; editors are able to draw on their far-reaching networks to help amplify the reach of the journal (and, in turn, your work).

• You can find our latest Call For Papers topics here.

Straightforward Submissions Processes

• Submit with ease using Editorial Manager.

• Use easy-to-follow Author Guidelines, including relaxed guidelines for initial submissions.

Article types

JNCI Cancer Spectrum publishes a range of content, including:

• Articles

• Systematic Reviews (with or without Meta-analysis) and Meta-analyses

• Brief Communications

• Correspondence

• Invited Responses

• Editorials

• Commentaries

• Reviews

• MiniReviews

Useful Next Steps

1. Sign up for e-alerts or follow the journal on X to stay up to date on any announcements and future calls for papers

2. Review the instructions to authors for information on journal policies and manuscript preparation

3. Log into our submission site.

Have a question? Contact our editorial office: [email protected]